DocGo (NASDAQ:DCGO – Get Free Report) and Auna (NYSE:AUNA – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, institutional ownership, profitability, earnings and risk.
Profitability
This table compares DocGo and Auna’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| DocGo | -65.29% | -40.42% | -24.81% |
| Auna | 0.44% | 12.88% | 3.24% |
Valuation & Earnings
This table compares DocGo and Auna”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| DocGo | $322.20 million | 0.12 | -$182.40 million | ($1.96) | -0.20 |
| Auna | $4.67 billion | 0.08 | $27.39 million | $0.07 | 74.94 |
Auna has higher revenue and earnings than DocGo. DocGo is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
56.4% of DocGo shares are owned by institutional investors. 5.1% of DocGo shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for DocGo and Auna, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| DocGo | 1 | 2 | 3 | 0 | 2.33 |
| Auna | 1 | 2 | 1 | 1 | 2.40 |
DocGo currently has a consensus target price of $2.38, indicating a potential upside of 512.11%. Auna has a consensus target price of $6.97, indicating a potential upside of 32.80%. Given DocGo’s higher probable upside, research analysts clearly believe DocGo is more favorable than Auna.
Volatility & Risk
DocGo has a beta of 0.94, suggesting that its stock price is 6% less volatile than the S&P 500. Comparatively, Auna has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500.
Summary
Auna beats DocGo on 9 of the 15 factors compared between the two stocks.
About DocGo
DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.
About Auna
Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
